Clinical and functional results after total scapulectomy in orthopedic oncology: are custom-made scapular prostheses better than humeral suspension?

Q3 Medicine Baylor University Medical Center Proceedings Pub Date : 2024-05-31 eCollection Date: 2024-01-01 DOI:10.1080/08998280.2024.2351313
Edoardo Ipponi, Martina Cordoni, Elena Bechini, Fabrizia Gentili, Fabio Cosseddu, Francesco Rosario Campo, Antonio D'Arienzo, Lorenzo Andreani
{"title":"Clinical and functional results after total scapulectomy in orthopedic oncology: are custom-made scapular prostheses better than humeral suspension?","authors":"Edoardo Ipponi, Martina Cordoni, Elena Bechini, Fabrizia Gentili, Fabio Cosseddu, Francesco Rosario Campo, Antonio D'Arienzo, Lorenzo Andreani","doi":"10.1080/08998280.2024.2351313","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In orthopedic oncology, total scapulectomy is necessary to allow a wide resection of extended malignancies of the scapula and scapular girdle. Scapular reconstruction is challenging even for the most experienced surgeon. This paper reports our experience with total scapular resections, followed by humeral suspension or custom-made prostheses.</p><p><strong>Methods: </strong>In this retrospective study, we evaluated all the oncologic patients treated in our institution between 2016 and 2023 with total scapulectomy and consequential reconstruction using humeral suspension or a custom-made prosthesis. Only cases suffering from malignant bone tumors were included. The postoperative functionality of the treated limbs was assessed using the Musculoskeletal Tumor Society (MSTS) scoring scale. Complications and local recurrences were also recorded.</p><p><strong>Results: </strong>Nine patients were enrolled. Five had custom-made implants, and four had humeral suspensions. The mean postoperative MSTS score of patients treated with custom-made prostheses was 24.0 (22-26). Globally, our cohort's mean MSTS score was 19.1 (9-26). Patients with custom-made prostheses had significantly better functional outcomes (MSTS 24 vs 13) and similar complication rates (40% vs 50%) than those who received humeral suspensions.</p><p><strong>Conclusion: </strong>Our outcomes suggest that, when feasible, custom-made scapular prostheses can represent a reliable reconstructive option after total scapulectomy for malignant scapular tumors.</p>","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"37 4","pages":"553-559"},"PeriodicalIF":0.0000,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11188788/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Baylor University Medical Center Proceedings","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/08998280.2024.2351313","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In orthopedic oncology, total scapulectomy is necessary to allow a wide resection of extended malignancies of the scapula and scapular girdle. Scapular reconstruction is challenging even for the most experienced surgeon. This paper reports our experience with total scapular resections, followed by humeral suspension or custom-made prostheses.

Methods: In this retrospective study, we evaluated all the oncologic patients treated in our institution between 2016 and 2023 with total scapulectomy and consequential reconstruction using humeral suspension or a custom-made prosthesis. Only cases suffering from malignant bone tumors were included. The postoperative functionality of the treated limbs was assessed using the Musculoskeletal Tumor Society (MSTS) scoring scale. Complications and local recurrences were also recorded.

Results: Nine patients were enrolled. Five had custom-made implants, and four had humeral suspensions. The mean postoperative MSTS score of patients treated with custom-made prostheses was 24.0 (22-26). Globally, our cohort's mean MSTS score was 19.1 (9-26). Patients with custom-made prostheses had significantly better functional outcomes (MSTS 24 vs 13) and similar complication rates (40% vs 50%) than those who received humeral suspensions.

Conclusion: Our outcomes suggest that, when feasible, custom-made scapular prostheses can represent a reliable reconstructive option after total scapulectomy for malignant scapular tumors.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肿瘤骨科全肩胛骨切除术后的临床和功能效果:定制肩胛骨假体比肱骨悬吊更好吗?
背景:在骨科肿瘤学中,有必要进行全肩胛切除术,以便对肩胛骨和肩胛带的扩展性恶性肿瘤进行广泛切除。即使对经验最丰富的外科医生来说,肩胛骨重建也是一项挑战。本文报告了我们在肩胛骨全切除术后采用肱骨悬吊术或定制假体的经验:在这项回顾性研究中,我们评估了 2016 年至 2023 年期间在我院接受肩胛骨全切除术治疗的所有肿瘤患者,并使用肱骨悬吊术或定制假体进行了相应的重建。其中仅包括恶性骨肿瘤病例。采用肌肉骨骼肿瘤协会(MSTS)评分表对治疗肢体的术后功能进行评估。并记录了并发症和局部复发情况:九名患者入选。五名患者植入了定制假体,四名患者植入了肱骨悬吊假体。定制假体患者的术后MSTS平均得分为24.0(22-26)分。在全球范围内,我们队列的平均 MSTS 得分为 19.1(9-26)。与接受肱骨悬吊术的患者相比,接受定制假体治疗的患者的功能预后明显更好(MSTS 24 vs 13),并发症发生率(40% vs 50%)相似:我们的研究结果表明,在可行的情况下,定制肩胛假体可作为恶性肩胛肿瘤全肩胛切除术后的可靠重建选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.30
自引率
0.00%
发文量
245
期刊最新文献
The importance of screening and surveillance: Barrett's esophagus and esophageal cancer. A brief descriptive analysis of a pilot study of peer support training and supervision for Texas firefighters. Contrast-associated acute kidney injury: How can we do better? "In a word, partnership"-lessons from a student-led health fair. A review of professionalism in surgery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1